EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical utility of metagenomic next-generation sequencing in the diagnosis of severe influenza complicated by invasive pulmonary aspergillosis

Siqiang Niu, Limin Guo, Zhihai Li, Yanshan Liu, Limin Zhao

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1746504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Siqiang Niu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xinxiang Central Hospital, Xinxiang, Henan, China. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, Influenza, Human, High-Throughput Nucleotide Sequencing, Metagenomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The incidence and mortality of severe influenza complicated by invasive pulmonary aspergillosis (IPA) have risen markedly in recent years. This study aimed to evaluate the diagnostic performance of metagenomic next-generation sequencing (mNGS) for detecting IPA in patients with severe influenza.

Methods

Severe influenza patients with suspected of having IPA admitted to Xinxiang Central Hospital, Henan Province, China, from March 2020 to September 2025 were retrospectively enrolled. Bronchoalveolar lavage fluid (BALF) and blood were collected for fungal culture, galactomannan (GM) assay, and mNGS. Final classification into IPA and non-IPA groups was based on composite clinical and microbiological criteria. Sensitivity, specificity, and receiver operating characteristic curves were used to compare the diagnostic performance of the three methods.

Results

Comparison with traditional fungal culture and GM testing, mNGS provided significantly faster results. Among 189 patients suspected of severe influenza-associated IPA, mNGS demonstrated a sensitivity of 72.1% and a specificity of 80.2%. Its sensitivity was higher than that of fungal culture (28.6%), serum GM testing (37.6%), and BALF GM testing (44.1%); however, its specificity was slightly lower than that of fungal culture (89.5%), serum GM testing (84.3%), and BALF GM testing (81.3%). The area under the ROC curve (AUC) for mNGS was 0.76, which is higher than that for BALF GM testing (0.63), serum GM testing (0.61), and fungal culture (0.59). The combined diagnostic approach yielded an AUC of 0.83. Conclusion mNGS offers a rapid, sensitive and accurate solution for invasive pulmonary aspergillosis in severe influenza patients. It outperforms conventional fungal culture and galactomannan assays. Integrating mNGS with traditional diagnostic methods could substantially improve early detection and overall yield of IPA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisInfluenza, HumanHigh-Throughput Nucleotide SequencingMetagenomicsHumansBronchoalveolar Lavage FluidSensitivity and SpecificityRetrospective StudiesMannansGalactoseFemaleMaleMiddle AgedChinaROC CurveAdultAged

Stichwörter der Autor:innen

GM testdiagnosisinfluenzainvasive pulmonary aspergillosismetagenomic next-generation sequencing

Substanzen

MannansGalactosegalactomannan

Autor:innen und Institutionen

  • Xinxiang Central Hospital, Xinxiang, Henan, China.
  • Xinxiang Key Laboratory of Respiratory Diseases, Xinxiang, Henan, China.
  • Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
  • Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
  • People's Hospital of Henan University, Zhengzhou, Henan, China.

Zitieren

APA

Niu, S., Guo, L., Li, Z., Liu, Y., & Zhao, L. (2026). Clinical utility of metagenomic next-generation sequencing in the diagnosis of severe influenza complicated by invasive pulmonary aspergillosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1746504

Vancouver

Niu S, Guo L, Li Z, Liu Y, Zhao L. Clinical utility of metagenomic next-generation sequencing in the diagnosis of severe influenza complicated by invasive pulmonary aspergillosis. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1746504

BibTeX
@article{Niu2026,
  author = {Niu, Siqiang and Guo, Limin and Li, Zhihai and Liu, Yanshan and Zhao, Limin},
  title = {Clinical utility of metagenomic next-generation sequencing in the diagnosis of severe influenza complicated by invasive pulmonary aspergillosis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1746504}
}
Kostenlos starten →